J. F. Olivares-Quintero

GSK2801, a BAZ2/BRD9 Bromodomain Inhibitor, Synergizes with BET Inhibitors to Induce Apoptosis in Triple-Negative Breast Cancer

Steven P. Angus, Darshan Singh, N. Rashid, 2019, Molecular Cancer Research.

Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex.

James S. Duncan, Steven P. Angus, C. Perou, 2017, Cancer discovery.

FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036

Michael L. Gatza, Steven P. Angus, C. Fan, 2021, NPJ breast cancer.

Discrete Adaptive Responses to MEK Inhibitor in Subpopulations of Triple-Negative Breast Cancer

Darshan Singh, N. Sciaky, G. Johnson, 2020, Molecular Cancer Research.

Enhancer Remodeling During Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacological Targeting of the PTEFb Complex

C. Perou, Darshan Singh, Xiaping He, 2017 .